18+

CELLIVITY / ADULT ACCESS

Are you 18 or older?

CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.

Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Skip to content
CELLIVITY
HomeScience LibraryEvidence methodologyResearch Radar
🇬🇧EN⌄
🇬🇧EnglishEN🇭🇺MagyarHU🇹🇭ไทยTH🇷🇺РусскийRU
Independent evidence
HomeScience LibraryEvidence methodologyResearch Radar
← Science Library

Medical

Canagliflozin

SGLT2 inhibitor

Guide-level evidence orientationEvidence level D

Level D describes sparse or indirect human evidence for this exact question; read the conclusion for direction and limits.

This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.
ORIENTATION RECORDUseful starting context; question-specific review is still pending.

Do not treat the guide-level letter as a final conclusion, product claim or recommendation.

IN PLAIN LANGUAGE

Why people are interested

Helps the kidneys remove glucose from the blood. It has important medical uses, but healthy-ageing use has not been established.

Library trackMedical research
Last reviewed20 Aug 2026
Guide scopeIngredient research only
01

How it may work

Promotes urinary glucose excretion through SGLT2 inhibition.

02

What people have studied

Strong clinical outcomes exist for selected diabetes, kidney and heart indications; healthy-longevity use is unproven.

03

What to consider

Prescription risks include infections, dehydration and ketoacidosis.

04

Local pathway

Prescription medical context only.

Sources + indexes

See where the explanation comes from.

Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.

  1. 01canagliflozin aging — PubMed research index ↗
CELLIVITY

Independent evidence guides for human research.

Science LibraryHomeScience LibraryEvidence methodologyResearch Radar
BoundariesLegal and privacySafety boundariesPrivacy request / unsubscribe
Pre-release boundary

Unless a page explicitly says released, every product is a development record. No page confirms approval, stock, individual suitability or medical benefit. Educational content is not medical advice.

Full legal terms →
© 2026 CELLIVITY. Pre-launch.Riviera Jomtien, 29/111, Pattaya 20150, ThailandControlled contact route

CELLIVITY / STAY IN THE LOOP

Follow the next
chapter.

New product records, laboratory documents and release news. Choose to hear from us when there is something useful to share.

  • New laboratory documents
  • Product availability updates
  • News from CELLIVITY
18+ only. Optional email updates. You can unsubscribe at any time.
Canagliflozin — CELLIVITY Science Library